Indacaterol is a bronchodilator drug whose use was recently approved (November 2009) by the European Medicines Agency (EMA).
Indacaterol is a selective agonist of β2-adrenergic receptors belonging to the family of so-called ultra-LABAs (ltra Long Acting Beta-adrenoceptor Agonists, ie the agonists of the β2-adrenergic receptors with an ultra long duration of action).
Indacaterol - Chemical Structure
Due to its remarkable duration of action, indacaterol can be administered only once a day, unlike drugs such as formoterol and salmeterol (selective long-acting β2-adrenergic receptor agonists) which must be taken twice. per day.
